
Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

Ustekinumab is the first and only biologic that targets both cytokines interleukin (IL)-12 and IL-23.

Expanded indication for Rebinyn could allow patients with hemophilia B to participate in physical and social activities.

Compared to atorvastatin, rosuvastatin was associated with higher risks of blood in the urine and kidney failure that requires replacement therapy.

Many companies overlook the power that workplace culture can have on employee wellness and instead, focus relentlessly on financial metrics.

Health care systems have made great strides by examining the diversity and equity of staffing.

With the opioid epidemic raging out of control, pharmacists are essential warriors in the fight against this scourge.

Behavioral economics is a tool that can influence patient behaviors using concepts such as choice architecture, nudges, and loss aversion.

Investigators found that treatment of high-grade squamous intraepithelial lesions in patients with HIV reduced anal cancer incidence by approximately 57%.

Heavy alcohol intake and ALDH2 rs671 polymorphism are among many risk factors associated with increased risk of hepatocellular carcinoma and mortality in patients with hepatitis B virus-related cirrhosis.

Patients with past medical histories of immunoglobulin E-mediated hypersensitivity reactions to metronidazole and other antimicrobial agents may receive safe and effective treatment using desensitization protocols.

Researchers found high levels of childcare stress among female and racial minority health care workers, supporting new programs and wellbeing initiatives.

Phentermine and Topiramate ER (Qsymia) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management.

Men’s Bladder Control supplements promote bladder and prostate health.

A majority of long-term care patients who received a fourth vaccination against COVID-19 were found to have increased protection against the omicron variant.

The pandemic saw reductions in the supply of methadone but no disruption to the supply of more easily accessible buprenorphine, though disparities in supply were observed across states.

There is nothing that hurts us more when a pharmacist stands up and is not passionate about the job that we do and the care that we provide.

The findings of the phase 1b/2 CHRYSALIS-2 cohort will be presented at the International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer.

People who are afraid of shots or feel lightheaded and dizzy while near vaccine injection sites are less likely to get vaccinated against COVID-19.

It’s common practice to recommend heart failure patients follow low sodium diets, but research has shown this type of diet may worsen patient health for certain forms of the condition.

Government’s database include health care professionals in many categories, including pharmacists.

Brought to you by The Sassy Pharmacist

The immune responses to the Omicron variant waned substantially with neutralizing antibody levels decreasing 2.4- to 5.3-fold by 3 months after the booster dose.

Study shows that adult survivors of cancer had a 42% greater risk of CVD than people who did not have the disease.

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.

Fondaparinux sodium (Arixtra) is indicated for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.

L-Lysine is a protein source that supports collagen synthesis.

Currently, there is no treatment targeted for superoxide dismutase 1 amyotrophic lateral sclerosis, which has a life expectancy of 3 to 5 years from time of symptom onset.

After a second booster dose, efficacy against COVID-19 Omicron subvariants rose to 80% within the first 6 months, according to results of a study by the CDC.

The drug combination demonstrated a 64.5% confirmed objective response rate in individuals with unresectable locally advanced or metastatic urothelial cancer who are ineligible to receive cisplatin-based chemotherapy.